Your browser doesn't support javascript.
The NIH-led research response to COVID-19.
Collins, Francis; Adam, Stacey; Colvis, Christine; Desrosiers, Elizabeth; Draghia-Akli, Ruxandra; Fauci, Anthony; Freire, Maria; Gibbons, Gary; Hall, Matthew; Hughes, Eric; Jansen, Kathrin; Kurilla, Michael; Lane, H Clifford; Lowy, Douglas; Marks, Peter; Menetski, Joseph; Pao, William; Pérez-Stable, Eliseo; Purcell, Lisa; Read, Sarah; Rutter, Joni; Santos, Michael; Schwetz, Tara; Shuren, Jeffrey; Stenzel, Timothy; Stoffels, Paul; Tabak, Lawrence; Tountas, Karen; Tromberg, Bruce; Wholley, David; Woodcock, Janet; Young, John.
  • Collins F; National Human Genome Research Institute, Bethesda, MD, USA.
  • Adam S; The Foundation for the National Institutes of Health, North Bethesda, MD, USA.
  • Colvis C; National Center for Advancing Translational Sciences, Bethesda, MD, USA.
  • Desrosiers E; Merck, Rahway, NJ, USA.
  • Draghia-Akli R; The Janssen Pharmaceutical Companies of Johnson & Johnson, Titusville, NJ, USA.
  • Fauci A; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
  • Freire M; The Foundation for the National Institutes of Health, North Bethesda, MD, USA.
  • Gibbons G; National Heart, Lung, and Blood Institute, Bethesda, MD, USA.
  • Hall M; National Center for Advancing Translational Sciences, Bethesda, MD, USA.
  • Hughes E; Teva Pharmaceuticals, Tel Aviv, Israel.
  • Jansen K; Pfizer, New York, NY, USA.
  • Kurilla M; National Center for Advancing Translational Sciences, Bethesda, MD, USA.
  • Lane HC; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
  • Lowy D; National Cancer Institute, Bethesda, MD, USA.
  • Marks P; US Food and Drug Administration, Silver Spring, MD, USA.
  • Menetski J; The Foundation for the National Institutes of Health, North Bethesda, MD, USA.
  • Pao W; Pfizer, New York, NY, USA.
  • Pérez-Stable E; National Institute on Minority Health and Health Disparities, Bethesda, MD, USA.
  • Purcell L; Vir Biotechnology, San Francisco, CA, USA.
  • Read S; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
  • Rutter J; National Center for Advancing Translational Sciences, Bethesda, MD, USA.
  • Santos M; The Foundation for the National Institutes of Health, North Bethesda, MD, USA.
  • Schwetz T; Office of the Director, National Institutes of Health, Bethesda, MD, USA.
  • Shuren J; US Food and Drug Administration, Silver Spring, MD, USA.
  • Stenzel T; US Food and Drug Administration, Silver Spring, MD, USA.
  • Stoffels P; Galapagos, Mechelen, Belgium.
  • Tabak L; Office of the Director, National Institutes of Health, Bethesda, MD, USA.
  • Tountas K; The Foundation for the National Institutes of Health, North Bethesda, MD, USA.
  • Tromberg B; National Institute of Biomedical Imaging and Bioengineering, Bethesda, MD, USA.
  • Wholley D; The Foundation for the National Institutes of Health, North Bethesda, MD, USA.
  • Woodcock J; US Food and Drug Administration, Silver Spring, MD, USA.
  • Young J; Roche, Basel, Switzerland.
Science ; 379(6631): 441-444, 2023 02 03.
Article in English | MEDLINE | ID: covidwho-2307962
ABSTRACT
Investment, collaboration, and coordination have been key.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Biomedical Research / COVID-19 Type of study: Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Science Year: 2023 Document Type: Article Affiliation country: Science.adf5167

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Biomedical Research / COVID-19 Type of study: Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Science Year: 2023 Document Type: Article Affiliation country: Science.adf5167